Thursday, January 27, 2022

immunogenicity

India’s drug regulator approves study on mixing of Covaxin and Covishield doses

An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on July 29 had recommended granting permission for conducting the study.

We are in the endgame of pandemic in India: Harsh Vardhan

Union Health Minister said people should trust the science behind vaccines and ensure that their near and dear ones get vaccinated on time

Hyderabad-based Bharat Biotech starts phase III trials for Covaxin

The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR

Latest News

- Advertisement -